These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 33463059)

  • 1. Facing the challenge of viral mutations in the age of pandemic: Developing highly potent, broad-spectrum, and safe COVID-19 vaccines and therapeutics.
    Su S; Wang Q; Jiang S
    Clin Transl Med; 2021 Jan; 11(1):e284. PubMed ID: 33463059
    [No Abstract]   [Full Text] [Related]  

  • 2. COVID-19 global pandemic: vaccines and new monoclonal antibodies, aspects to be clarified.
    Ferrara F; Pianesi L; Vitiello A
    Immunol Res; 2021 Apr; 69(2):115-116. PubMed ID: 33860404
    [No Abstract]   [Full Text] [Related]  

  • 3. New generation of vaccines and convalescent plasma therapy for management of CoV-2: Perspectives from the UK and potential deployment in the current global pandemic.
    Seghatchian J
    Transfus Apher Sci; 2021 Feb; 60(1):103051. PubMed ID: 33461918
    [No Abstract]   [Full Text] [Related]  

  • 4. Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update.
    Anand U; Jakhmola S; Indari O; Jha HC; Chen ZS; Tripathi V; Pérez de la Lastra JM
    Front Immunol; 2021; 12():658519. PubMed ID: 34276652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viruses, variants and vaccines.
    Cowan DA; Burton SG; Rybicki EP; Wiliamson AL; Dorrington RA; Pepper MS
    S Afr Med J; 2021 Mar; 111(5):409-411. PubMed ID: 34852879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 evolution and vaccines: cause for concern?
    Williams TC; Burgers WA
    Lancet Respir Med; 2021 Apr; 9(4):333-335. PubMed ID: 33524316
    [No Abstract]   [Full Text] [Related]  

  • 7. SARS-CoV-2 variants and COVID-19 vaccines: Current challenges and future strategies.
    Gong W; Parkkila S; Wu X; Aspatwar A
    Int Rev Immunol; 2023; 42(6):393-414. PubMed ID: 35635216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Facing the wrath of enigmatic mutations: a review on the emergence of severe acute respiratory syndrome coronavirus 2 variants amid coronavirus disease-19 pandemic.
    Chadha J; Khullar L; Mittal N
    Environ Microbiol; 2022 Jun; 24(6):2615-2629. PubMed ID: 34320263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in gene-based vaccine platforms to address the COVID-19 pandemic.
    Pushparajah D; Jimenez S; Wong S; Alattas H; Nafissi N; Slavcev RA
    Adv Drug Deliv Rev; 2021 Mar; 170():113-141. PubMed ID: 33422546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In subjects 16 years of age and older, is messenger RNA vaccine BNT162b2 against COVID-19 effective and safe?].
    Lanthier L; Carignan A; Plourde MÉ; Cauchon M
    Rev Med Interne; 2021 Mar; 42(3):227-228. PubMed ID: 33612319
    [No Abstract]   [Full Text] [Related]  

  • 11. Covid mutations: honest approach needed from politicians and scientists on pandemic outlook.
    Dagli M
    BMJ; 2021 Mar; 372():n656. PubMed ID: 33688056
    [No Abstract]   [Full Text] [Related]  

  • 12. COVID-19 mRNA vaccines.
    Huang Q; Zeng J; Yan J
    J Genet Genomics; 2021 Feb; 48(2):107-114. PubMed ID: 34006471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 vaccines: Keeping pace with SARS-CoV-2 variants.
    Cevik M; Grubaugh ND; Iwasaki A; Openshaw P
    Cell; 2021 Sep; 184(20):5077-5081. PubMed ID: 34534444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleic Acid-Based Technologies Targeting Coronaviruses.
    Le TK; Paris C; Khan KS; Robson F; Ng WL; Rocchi P
    Trends Biochem Sci; 2021 May; 46(5):351-365. PubMed ID: 33309323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 Variants, Vaccines, and Host Immunity.
    Mistry P; Barmania F; Mellet J; Peta K; Strydom A; Viljoen IM; James W; Gordon S; Pepper MS
    Front Immunol; 2021; 12():809244. PubMed ID: 35046961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenoviral Vector DNA- and SARS-CoV-2 mRNA-Based Covid-19 Vaccines: Possible Integration into the Human Genome - Are Adenoviral Genes Expressed in Vector-based Vaccines?
    Doerfler W
    Virus Res; 2021 Sep; 302():198466. PubMed ID: 34087261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Era of the Coronavirus Disease 2019 Pandemic: A Review on Dynamics, Clinical Symptoms and Complications, Diagnosis, and Treatment.
    Younis NK; Zareef RO; Maktabi MAN; Mahfouz R
    Genet Test Mol Biomarkers; 2021 Feb; 25(2):85-101. PubMed ID: 33596144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccines, therapeutics, and diagnostics for covid-19: redesigning systems to improve pandemic response.
    Ramchandani R; Kazatchkine M; Liu J; Sudan P; Dybul M; Matsoso P; Nordström A; Phelan A; Legido-Quigley H; Singh S; Mabuchi S
    BMJ; 2021 Nov; 375():e067488. PubMed ID: 34840135
    [No Abstract]   [Full Text] [Related]  

  • 19. A network analysis of COVID-19 mRNA vaccine patents.
    Gaviria M; Kilic B
    Nat Biotechnol; 2021 May; 39(5):546-548. PubMed ID: 33981074
    [No Abstract]   [Full Text] [Related]  

  • 20. Genetics and genomics of SARS-CoV-2: A review of the literature with the special focus on genetic diversity and SARS-CoV-2 genome detection.
    Rahimi A; Mirzazadeh A; Tavakolpour S
    Genomics; 2021 Jan; 113(1 Pt 2):1221-1232. PubMed ID: 33007398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.